Case Presentation: We present a case of a 65 year old female with a recent diagnosis of small cell lung cancer (SCLC) who had completed four cycles of carboplatin and etoposide. She was subsequently initiated on maintenance program cell death ligands (PD-L1) inhibitor, atezolizumab every three weeks since January 2019. Seven months after initiation, she […]

Case Presentation: Patient is a previously healthy 11-year old Hispanic female who presented to an emergency department with altered mental status, opus-myoclonus movements, aphasia, hallucinations and slurred speech. Six weeks prior to presentation, patient had been treated for an acute tonsillitis infection with Penicillin therapy. Soon after, she developed involuntary movements with progression to neurological […]